Company intelligence / Profile preview

Able Biolabs

Ownership: Private
Development stage: Other

Overview

Able Biolabs offers expert preclinical and clinical R&D services to biotech and consumer goods industries. It specializes in custom model development, in vitro/ex vivo/in vivo studies using traditional cell-based systems, organoids, small animals, as well as decentralized clinical trials. The company collaborates with SRI International for GLP work and has advisory relationships with the University of Alabama at Birmingham.

Modalities: Small moleculeBiologicRecombinant proteinPeptides
Industry: Drug Discovery Services

Partnerships

SRI International – collaboration to expand preclinical service portfolio for biotech/biopharma clients.

Beyond the preview

Go deeper on Able Biolabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Able Biolabs.

Explore the full profile